L-carnitine in tuberculosis

INTERVENTION: Intervention 1: l‐carnitine 10cc,BID,PO for 4weeks. Intervention 2: l‐carnitine placebo ,10cc,BID,PO for 4weeks. l‐carnitine 10cc,BID,PO for 4weeks l‐carnitine placebo ,10cc,BID,PO for 4weeks Placebo Treatment ‐ Drugs CONDITION: A15,A16,A1 Tuberculosis Tuberculosis. ; Tuberculosis PRIMARY OUTCOME: Hepatotoxicity. Timepoint: At the begining of study and after 4weeks. Method of measurement: Liver enzyme and clinical sign and symptom. INCLUSION CRITERIA: INCLUSION CRITERIA:Tuberculosis diagnosis according to microbiological,clinical,pathological and epidemiological evidences and anti‐ tuberculosis treatment, Consent form signing 3.No history of carnitine or multivitamin use during last 8week, Age >18y, No history of Anti‐Epileptic drugs use 6.No history of renal or liver disease,No history of thyroid abnormalities ‐Exclusion criteria: Having adverse drug reaction(eg.hypertention,diaherra), Patient's refusal to participate in the study